Cargando…
COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) is the first pandemic caused by coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there is no effective anti-SARS-CoV-2 drug approved worldwide for treatment of patients with...
Autores principales: | Guan, Wenyi, Lan, Wendong, Zhang, Jing, Zhao, Shan, Ou, Junxian, Wu, Xiaowei, Yan, Yuqian, Wu, Jianguo, Zhang, Qiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524871/ https://www.ncbi.nlm.nih.gov/pubmed/32997322 http://dx.doi.org/10.1007/s12250-020-00297-0 |
Ejemplares similares
-
COVID-19: Coronavirus Vaccine Development Updates
por: Zhao, Jing, et al.
Publicado: (2020) -
Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020) -
Characterization of Influenza A and B Viruses Circulating in Southern China During the 2017–2018 Season
por: Yan, Yuqian, et al.
Publicado: (2020) -
Development and Application of a Fast Method to Acquire the Accurate Whole-Genome Sequences of Human Adenoviruses
por: Zhao, Shan, et al.
Publicado: (2021) -
Molecular Typing and Rapid Identification of Human Adenoviruses Associated With Respiratory Diseases Using Universal PCR and Sequencing Primers for the Three Major Capsid Genes: Penton Base, Hexon, and Fiber
por: Wu, Xiaowei, et al.
Publicado: (2022)